Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma

Liver International

Volumn 34, Issue 4, 2014, Pages 632-642

  Choi, Sung Hoon ^a   Kwon, Oh Joon ^b   Park, Jun Yong ^a,c   Kim, Do Young ^a,c   Ahn, Sang Hoon ^a,c   Kim, Seung Up ^a,c   Ro, Simon Weonsang ^a,c   Kim, Kyung Sik ^a,c   Park, Jeon Han ^a   Kim, Seungtaek ^a   Yun, Chae Ok ^b   Han, Kwang Hyub ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Hypoxia inducible factor 1 alpha; Interleukin 8; Tumour xenograft

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; SHORT HAIRPIN RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SIZE; CANCER SURVIVAL; CAPILLARY DENSITY; CARCINOMA CELL; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROCEDURES; SURVIVAL RATE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS; HEPATOCELLULAR CARCINOMA; HYPOXIA INDUCIBLE FACTOR-1 ALPHA; INTERLEUKIN-8; TUMOUR XENOGRAFT;

ADENOVIRIDAE; ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; INTERLEUKIN-8; LIVER NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84895821904     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12375     Document Type: Article

References (28)

1. Semela D, Dufour JF. Angiogenesis and hepatocellular carcinoma. J Hepatol 2004; 41: 864-80.
2. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version1.0. International Agency for Research on Cancer Cancer Base no 5 Lyon, France: IARC Press, 2001.
3. Yoshiji H, Kuriyama S, Yoshii J, et al. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Hepatology 1998; 28: 1489-96.
4. Yamaguchi R, Yano H, Nakashima Y, et al. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep 2000; 7: 725-9.
5. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003; 9: 677-84.
6. Longo R, Sarmiento R, Fanelli M, et al. Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis 2002; 5: 237-56.
7. Weidemann A, Johnson R. Biology of HIF-1α. Cell Death Differ 2008; 15: 621-7.
8. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
9. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735-41.
10. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6: 447-58.
11. Chavey C, Muhlbauer M, Bossard C, et al. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer. Mol Pharmacol 2008; 74: 1359-66.
12. Mizukami Y, Jo WS, Duerr EM, et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 2005; 11: 992-7.
13. Arany Z, Foo SY, Ma Y, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008; 451: 1008-12.
14. Yoo JY, Kim JH, Kim J, et al. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition. Gene Ther 2008; 15: 635-51.
15. Vosseler S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res 2005; 65: 1294-305.
16. Onuta G, Westerweel PE, Zandvoort A, et al. Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes. Microvasc Res 2008; 75: 420-5.
17. Shimamura T, Saito S, Morita K, et al. Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens. J Gastroenterol Hepatol 2000; 15: 640-6.
18. Gadaleta CD, Ranieri G. Trans-arterial chemoembolization as a therapy for liver tumours: new clinical developments and suggestions for combination with angiogenesis inhibitors. Crit Rev Oncol Hematol 2011; 80: 40-53.
19. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
20. Kress S, Stein A, Maurer P, et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 1998; 124: 315-20.
21. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32.
22. Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 2009; 284: 6038-42.
23. Pang RW, Poon RT. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 2007; 72(Suppl. 1): 30-44.
24. Hopfl G, Wenger RH, Ziegler U, et al. Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res 2002; 62: 2962-70.
25. El-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998; 27: 1554-62.
26. Chen J, Kobayashi M, Darmanin S, et al. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am J Pathol 2009; 175: 400-11.
27. Choi SH, Shin HW, Park JY, et al. Effects of the knockdown of hypoxia inducible factor-1alpha expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines. Korean J Hepatol 2010; 16: 280-7.
28. Rao DD, Vorhies JS, Senzer N, Nemunaitis J. siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 2009; 61: 746-59.